Appili Therapeutics Inc. (APLI.TO)
CAD 0.04
(-12.5%)
CAD 0.04
(-12.5%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 827.4 Thousand | 334.17 Thousand | 1.39 Million | - | 199.1 Thousand | - |
| Cost of Revenue | 13.66 Thousand | 6266.00 | - | 14.83 Thousand | - | 20.71 Thousand |
| Gross Profit | 813.74 Thousand | 327.91 Thousand | 1.39 Million | -14.83 Thousand | 199.1 Thousand | -20.71 Thousand |
| Operating Expenses | 8.83 Million | 8.1 Million | 24.94 Million | 16.28 Million | 5.6 Million | 7.14 Million |
| Selling, General and Administrative Expenses | 3.19 Million | 4.43 Million | 4.55 Million | 4.79 Million | 3.27 Million | 3.21 Million |
| Research and Development Expenses | 5.64 Million | 3.8 Million | 21.45 Million | 11.49 Million | 3.02 Million | 3.92 Million |
| Other Expenses | - | - | -1.06 Million | -1.28 Million | -687.4 Thousand | -2.17 Million |
| Cost and Expenses | 8.85 Million | 8.1 Million | 24.94 Million | 16.29 Million | 5.6 Million | 7.16 Million |
| Operating Income | -8.05 Million | -7.91 Million | -24.67 Million | -16.29 Million | -6.13 Million | -7.16 Million |
| Interest Expense | 1.63 Million | 1.09 Million | 1.55 Million | 69.83 Thousand | 12.1 Thousand | - |
| Income Tax Expense | 39.86 Thousand | 36.39 Thousand | 38.45 Thousand | -627.89 Thousand | 727.56 Thousand | -621.6 Thousand |
| Earnings before Tax | -3.74 Million | -9.2 Million | -25.07 Million | -14.95 Million | -5.41 Million | -4.95 Million |
| Net Income | -3.78 Million | -9.24 Million | -25.11 Million | -14.32 Million | -5.41 Million | -4.33 Million |
| Earnings Per Share Basic | -0.03 | -0.08 | -0.38 | -0.24 | -0.16 | -0.14 |
| Earnings Per Share Diluted | -0.03 | -0.08 | -0.38 | -0.24 | -0.16 | -0.14 |
| Weighted Average Shares Outstanding | 121.26 Million | 113.73 Million | 66.73 Million | 59.17 Million | 34.32 Million | 30.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.26 Million | 113.73 Million | 66.73 Million | 59.17 Million | 34.32 Million | 30.28 Million |
| Gross Margin | 0.98 | 0.98 | 1.00 | - | 1.00 | - |
| EBIT Margin | -2.53 | -23.16 | -16.91 | - | -27.05 | - |
| Profit Margin | -4.57 | -27.66 | -18.06 | - | -27.20 | - |
| EBITDA | -2.09 Million | -8.19 Million | -24.31 Million | -14.86 Million | -5.63 Million | -4.93 Million |
| Earnings Before Tax Margin | -9.73 | -23.68 | -17.75 | - | -30.80 | - |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | 827.4 Thousand | 11.69 Thousand | 478.39 Thousand | 337.31 Thousand | - |
| Cost of Revenue | 3365.00 | 13.66 Thousand | 3219.00 | 3393.00 | 3442.00 | 3442.00 |
| Gross Profit | -3365.00 | 813.74 Thousand | 8478.00 | 475 Thousand | 333.87 Thousand | -3442.00 |
| Operating Expenses | 2.78 Million | 8.83 Million | 2.42 Million | 328.9 Thousand | 755.34 Thousand | 1.3 Million |
| Selling, General and Administrative Expenses | 762.61 Thousand | - | 835.69 Thousand | 564.7 Thousand | 732.23 Thousand | 932.71 Thousand |
| Research and Development Expenses | 2.01 Million | - | 1.58 Million | 1.83 Million | 1.08 Million | 1.29 Million |
| Other Expenses | -2.48 Million | - | - | - | - | - |
| Cost and Expenses | 2.78 Million | 8.85 Million | 2.42 Million | 328.9 Thousand | 755.34 Thousand | 1.3 Million |
| Operating Income | -2.78 Million | -8.02 Million | -2.41 Million | 155.07 Thousand | -415.68 Thousand | -2.23 Million |
| Interest Expense | 1.23 Million | 1.63 Million | 382.91 Thousand | 438.62 Thousand | 428.17 Thousand | 381.28 Thousand |
| Income Tax Expense | -5.00 | 39.86 Thousand | 8957.00 | 6089.00 | 42.03 Thousand | 12.5 Thousand |
| Earnings before Tax | -1.58 Million | -3.74 Million | -1.09 Million | -146.24 Thousand | -934.51 Thousand | -1.53 Million |
| Net Income | -1.58 Million | -3.78 Million | -1.1 Million | -152.33 Thousand | -976.55 Thousand | -1.54 Million |
| Earnings Per Share Basic | -0.01 | - | -0.01 | -0.00 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | - | -0.01 | -0.00 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million |
| Gross Margin | - | 0.98 | 0.72 | 0.99 | 0.99 | - |
| EBIT Margin | - | - | -206.33 | 0.33 | -1.22 | - |
| Profit Margin | - | -4.57 | -94.34 | -0.32 | -2.90 | - |
| EBITDA | -2.78 Million | - | -2.41 Million | 158.46 Thousand | -412.24 Thousand | -1.29 Million |
| Earnings Before Tax Margin | - | -9.70 | -206.61 | 0.32 | -1.23 | - |
QMCI
NA
BANSWRAS
ANUP
SUPER
SAML